Tamoxifen aziridine binding to cytosolic proteins from human breast specimens is negatively associated with estrogen receptors, progesterone receptors, pS2, and cathepsin-D-Reference-Cited by-同舟云学术

Tamoxifen aziridine binding to cytosolic proteins from human breast specimens is negatively associated with estrogen receptors, progesterone receptors, pS2, and cathepsin-D

Published:1998-07 Issue:2 Volume:50 Page:155-166
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Navarro Domingo,Doreste Hilario,Cabrera Juan J.,Morales Manuel,Díaz-Chico Juan C.,Díaz-Chico Bonifacio N.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.springerlink.com/index/pdf/10.1023/A:1006062510883

Reference36 articles.

1. Jensen EV: Estrogen receptors in hormone-dependent breast cancers. Cancer Res 35: 3362–3364, 1975

2. Katzenellenbogen BS, Montano MM, Le Goff P, Schodin DJ, Kraus WL, Bhardwaj B, Fujimoto N: Antiestrogens: mechanism and actions in target cells. J Steroid Biochem Mol Biol 53: 387–393, 1995

3. McGuire WL: Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin Oncol 5: 428–433, 1978

4. Osborne CK, Fuqua SA: Mechanisms of tamoxifen resistance. Breast Cancer Res Treat 32: 49–55, 1994

5. Garcia T, Lehrer S, Bloomer WD, Schachter B: A variant estrogen receptor messenger ribonucleic acid is associated with reduced levels of estrogen binding in human mammary tumors. Mol Endocrinol 2: 785–791, 1988

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular forms of the estrogen receptor in breast cancer;The Journal of Steroid Biochemistry and Molecular Biology;2002-03